January 23, 2021
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
International Diplomacy International Diplomacy
top
International Diplomacy
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
Menu
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
loading...
Latest Articles
  • More cases of Covid variants confirmed – Ministry of Health
  • Pfizer-BioNTech vaccine found to be effective against Covid variant discovered in UK
  • Italy avoids government collapse as Prime Minister Giuseppe Conte survives confidence vote
  • Russia detains Navalny for 30 days; Kremlin critic urges supporters to ‘take to the streets’
  • Powell sees no interest rate hikes on the horizon as long as inflation stays low
  • House to impeach Trump for inciting Capitol attack as more Republicans get on board
  • Coronavirus mutations: Here are the major Covid strains we know about
  • Germany’s Merkel hits out at Twitter over ‘problematic’ Trump ban
  • Germany’s Merkel ‘open’ to producing Russian Covid vaccine in the EU
  • Exporters face ‘real test’ now as post-Brexit arrangements kick in
Home European Medicines Agency
EU’s initial green-light to remdesivir might be granted in coming days - EMA

EU’s initial green-light to remdesivir might be granted in coming days – EMA

Posted By: Editorial Teamon: May 18, 2020In: NEWSNo Comments

The head of the European Union’s medicines agency Guido Rasi said on Monday an initial authorization for U.S. pharmaceutical company Gilead’s remdesivir as a Covid-19 treatment could be granted in coming days. “It might be that a conditional market authorization can be issued in the coming days,” Rasi told a hearing in the EU Parliament […] Read more

Share 0
Tweet
Share
Share
Share

Advertising

services
solutions
vrp

2018 Powered By GroupW

  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES